基线蛋白尿水平对狼疮肾炎长期结局的影响
研究纳入249例首次活检证实的狼疮肾炎患者,按基线蛋白尿分为低水平(≤1 g/天,62例)、中水平(>1且<3 g/天,90例)和高水平(≥3 g/天,97例)三组。中位随访8.4年,高水平蛋白尿组不良复合结局和复发频率最高,低水平蛋白尿常与增殖性病变和不良长期结局相关。
要点
- 低水平蛋白尿(≤1 g/天)组中59.7%有增殖性病变,常与增殖性狼疮肾炎相关。
- 高水平蛋白尿(≥3 g/天)组不良复合结局频率48.5%,高于低水平组27.4%和中水平组26.7%(P=0.003)。
- 高水平蛋白尿组复发频率61.9%,高于低水平组27.4%和中水平组38.2%(P<0.001)。
核心结论
- 低水平蛋白尿常与增殖性狼疮肾炎及不良长期结局相关。
研究设计与样本
- 纳入249例首次活检证实的狼疮肾炎患者,按基线蛋白尿水平分为低水平(≤1 g/天,62例)、中水平(>1且<3 g/天,90例)和高水平(≥3 g/天,97例)三组。
- 采用Cox比例风险模型检验基线特征与长期结局的关联。
主要发现
- 基线中位年龄33.2(IQR 26.4–42.4)岁,中位蛋白尿2.2(IQR 1.0–3.8)g/天。
- 活检增殖性病变总体177例(71%),低水平组59.7%、中水平组78.9%、高水平组71.4%。
- 1年完全蛋白尿恢复率低水平组最高、高水平组最低。
- 中位随访8.4年,不良复合结局(ESKD、eGFR持续下降≥40%或死亡)频率低水平组27.4%、中水平组26.7%、高水平组48.5%(P=0.003)。
- 复发频率低水平组27.4%、中水平组38.2%、高水平组61.9%(P<0.001);多变量模型中低水平组与中水平组无显著差异,高水平组预后最差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Proteinuria is a marker of lupus nephritis (LN) activity and damage. We aimed to explore the impact of baseline proteinuria level on long-term outcomes. METHODS: We included 249 patients diagnosed with their first biopsy-proven LN. We divided patients based on baseline proteinuria into low-level (≤1 g/day, group 1; 62 patients), moderate-level (>1 and <3 g/day, group 2; 90 patients) and high-level proteinuria (≥3 g/day, group 3; 97 patients). Outcomes included complete proteinuria recovery (CPR) at 1 year, an adverse composite outcome (ESKD, a sustained ≥40% decline in eGFR, or death) and LN flares. Cox proportional hazard models were used to examine the association between baseline characteristics and long-term outcomes. RESULTS: At baseline, the median [IQR] age was 33.2 [26.4, 42.4] years; median proteinuria level was 2.2 [1.0, 3.8] g/day. A total of 177 (71%) patients had proliferative lesions on biopsy; 59.7% in group 1, 78.9% in group 2 and 71.4% in group 3. The rate of achievement of CPR at 1 year was highest for group 1 and lowest for group 3. For long-term outcomes (median follow-up 8.4 years), the frequency of the adverse composite outcome was 27.4%, 26.7% and 48.5% in groups 1, 2 and 3, respectively; P = 0.003. The corresponding frequency of flares was 27.4%, 38.2% and 61.9%, respectively; P < 0.001. In the multivariable model for factors associated with long-term outcomes, there was no significant difference between groups 1 and 2; group 3 was associated with the worst prognosis. CONCLUSIONS: Low-level proteinuria is commonly associated with proliferative LN and adverse long-term outcomes.
引用
- Kharouf F, Li Q, Whittall Garcia LP, et al. Impact of baseline proteinuria level on long-term outcomes in lupus nephritis. Rheumatology (Oxford). 2025. PMID: 39447055. doi:10.1093/rheumatology/keae579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。